W. Cheng

CD19/BAFF-R dual targeted CAR T cells for treatment of mixed antigen-negative variants of acute lymphoblastic leukemia

Xiuli Wang, L. Kwak, I. Aldoss, 2021, Leukemia.

Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions

Xiuli Wang, L. Kwak, S. Forman, 2020, Cancer Immunology, Immunotherapy.

CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies

G. Inghirami, Xiuli Wang, L. Kwak, 2019, Science Translational Medicine.

Targeting myeloid-derived suppressor cells for cancer immunotherapy

L. Kwak, Guowei Wei, H. Qin, 2018, Cancer Immunology, Immunotherapy.

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo

L. Kwak, L. Bover, S. Neelapu, 2017, Clinical Cancer Research.

CD19/BAFF-R dual targeted CAR T cells for treatment of mixed antigen-negative variants of acute lymphoblastic leukemia

Xiuli Wang, L. Kwak, I. Aldoss, 2021, Leukemia.